Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sanofi (SNY) Shares Outstanding (Diluted Average) (2016 - 2025)

Sanofi's Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $1.4 billion for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 6.29% to $1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 6.29% increase, with the full-year FY2025 number at $1.4 billion, up 6.29% from a year prior.
  • Shares Outstanding (Diluted Average) hit $1.4 billion in Q4 2025 for Sanofi, up from $2.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for SNY hit a ceiling of $1.4 billion in Q4 2021 and a floor of $1.9 million in Q2 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $685.4 million across 5 years, with a median of $642.7 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 67.41% in 2021 and later surged 40.35% in 2025.
  • Tracing SNY's Shares Outstanding (Diluted Average) over 5 years: stood at $1.4 billion in 2021, then dropped by 10.82% to $1.3 billion in 2022, then rose by 5.42% to $1.4 billion in 2023, then dropped by 0.71% to $1.3 billion in 2024, then grew by 6.29% to $1.4 billion in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SNY at $1.4 billion in Q4 2025, $2.7 million in Q2 2025, and $1.3 billion in Q4 2024.